Exemasin 25 contains Exemestane 25 mg, an aromatase inhibitor used in the hormonal treatment of certain hormone-receptor-positive breast cancers in postmenopausal women. Exemestane works by reducing the body's production of estrogen, which can help limit estrogen-dependent cancer-cell growth.
Treatment should be prescribed and monitored by a qualified oncology professional. The choice and duration of therapy depend on the patient's diagnosis, menopausal status, previous treatment and applicable clinical guidelines.
